(1)
Cao, Z.; Sui, E.; Wu, Y. Behavior and Consequences of COVID-19-Related Voluntary Disclosure: Evidence from Pharmaceutical Companies. BCPBM 2022, 31, 378-391. https://doi.org/10.54691/bcpbm.v31i.2653.